Self microemulsifying drug delivery system: A method for enhancement of bioavailability

International Journal of Pharmaceutical Sciences

Volumn 3, Issue 1, 2012, Pages 66-79

  Goyal, Urvashi ^a   Gupta, Ankit ^a   Rana, Avtar Chand ^a   Aggarwal, Geeta ^a  

^a Rayat Institute of Pharmacy   (India)

Author keywords

Lipophilic drug; Oral bioavailability; SMEDDS; Solid SMEDDS

Indexed keywords

ANIONIC SURFACTANT; CATIONIC SURFACTANT; COSURFACTANT; ENZYME INHIBITOR; IONIC SURFACTANT; KETOPROFEN; LIPID; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; NONIONIC SURFACTANT; OIL; ORGANIC SOLVENT; PACLITAXEL; POLYMER; PROGESTERONE; SOLVENT; SURFACTANT;

AREA UNDER THE CURVE; CENTRIFUGATION; COOLING; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DETERMINATION; DRUG FORMULATION; DRUG SAFETY; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; FREEZE THAWING; HEATING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MICROEMULSION; MICROENCAPSULATION; MOLECULAR SIZE; NONHUMAN; REFRACTION INDEX; REVIEW; SUSTAINED RELEASE FORMULATION; THERMODYNAMICS; THERMOSTABILITY; TURBIDIMETRY; ZETA POTENTIAL;

EID: 84859054641     PISSN: None     EISSN: 09754725     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Stegemanna S and Leveillerb F: When poor solubility becomes an issue: From early stage to proof of concept. European Journal of Pharmaceutical Sciences 2007; 31:249-61.
2. Sachan R, Khatri K and Kasture SB: Self-emulsifying drug delivery system: A novel approach for enhancement of bioavalibility. International Journal of PharmTec Research 2010; 2:1738-1745.
3. Aungst BJ: Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. Journal of Pharmaceutical Sciences 1993; 81:979-986.
4. Burcham DL, Maurin MB, Hausner EA and Huang SM: Improved oral bioavailability of the hypocholesterolemic DMP 565 in dogs following oral dosing in oil and glycol solutions. Biopharmaceutics & Drug Disposition 1997; 18:737-742.
5. Serajuddin AT, Sheen PC, Mufson D, Bernstein DF and Augustine MA: Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water soluble drug from solid dispersion. Journal of Pharmaceutical Sciences 1988; 77:414-417.
6. Aungst BJ, Nguye N, Rogers NJ, Rowe S, Hussain M, Shum L and White S: Improved oral bioavailability of an HIV protease inhibitor using gelucire 44/14 and labrasol vehicles. Bulletin Technique Gattefosse 1994; 87:49-54.
7. Wakerly MG, Pouton CW, Meakin BJ and Morton FS: Self- emulsification of vegetable oil-non-ionic surfactant mixtures. ACS Symposium Series 1986; 311:242-255.
8. Craig DQM, Lievens HSR, Pitt KG and Storey DE: An investigation into the physicochemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis. International Journal of Pharmaceutics 1993; 96:147-155.
9. Toguchi H, Ogawa Y, Iga K, Yashiki T and Shimamoto T: Gastro- intestinal absorption of ethyl 2 chloro-3-(4-(2- methyl-2- phenylpropyloxy) phenyl) propionate from different dosage forms in rats and dogs. Chemical & Pharmaceutical Bulletin 1990; 38:2792- 2796.
10. Kararli TT, Needham TE, Griffin M, Schoenhard G and Ferro LJ: Alcorn L oral delivery of a renin inhibitor compound using emulsion formulations. Pharmaceutical Research 1992; 9:888-93.
11. Schwendener RA and Schott H: Lipophilic 1-beta-darabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model. Journal of Cancer Research & Clinical Oncology 1996; 122:723-726.
12. Patel PA, Chaulang GM, Akolkotkar A, Mutha SS, Hardikar SR and Bhosale AV: Self-emulsifying drug delivery system: A review. Research Journal of Pharmacy & Technology 2008; 1:313-324.
13. Corbo DC, Liu JC and Chein YW: Characterization of the barrier properties of mucosal membranes, Journal of Pharmaceutical Sciences 1990; 79:202-206.
14. Wakerly MG, Pouton CW and Meakin BJ: Evaluation of the self- emulsifying performance of a non-ionic surfactant-vegetable oil mixture. Journal of Pharmacy & Pharmacology 1987; 39:6p.
15. Constantinides PP: Lipid microemulsion for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspect. Pharmaceutical Research 1995; 12:1561-1572.
16. Shah NH, Carvagal MT, Patel CI, Infild MH and Malick AW: Self- emulsifying drug delivery system (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. International Journal of Pharmaceutics 1994; 106:15-23.
17. Gupta RN, Gupta R and Singh RG: Enhancement of oral bioavailability of lipophilic drugs from self-microemulsifying drug delivery system (SMEDDS). International Journal of Drug Development & Research 2009; 1:10-18.
18. Kyatanwar AU, Jadhav KR and Kadam VJ: Self micro-emulsifying drug delivery system (SMEDDS): Review. Journal of Pharmaceutical Research 2010; 3:75-83.
19. Wakerly MG, Pouton CW, Meakin BJ and Morton FS: Self- emulsification of vegetable oil-non-ionic surfactant mixtures: A proposed mechanism of action. ACS symposium Series 1986; 311:242-255.
20. Pouton CW: Effects of the inclusion of a model drug on the performance of self-emulsifying formulations. Journal of Pharmacy & Pharmacology 1985; 37:1p.
21. Tang JL, Sun J and He ZG: Self-emulsifying drug delivery system: Strategy for improving oral delivery of poorly soluble drugs. Current Drug Therapy 2007; 2:85-93.
22. Pouton CW and Charman WN: The potential of oily formulations for drug delivery to the gastro-intestinal tract. Advanced Drug Delivery Review 1997; 25:1-2.
23. Cirri M, Mura P and Mora PC: Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems. International Journal of Pharmaceutics 2007; 340: 84-91.
24. Zvonar A, Berginc K, Kristl A and Gasperlin M: Microencapsulation of self-microemulsifying system: Improving solubility and permeability of furosemide. International Journal of Pharmaceutics 2010; 388:151-158.
25. Shukla JB and Patel SJ: Formulation and evaluation of self- microemulsifying system of candesartan cilexetil. International Journal of Pharmaceutical Sciences 2010; 2:143-146.
26. Yao J, Lu Y and Zhou JP: Preparation of nobiletin in self- microemulsifying systems and its intestinal permeability in rats. Journal of Pharmaceutical Sciences 2008; 3:22-29.
27. Lu JL, Wang JC, Zhao SX, Liu XY, Zhao H, Zhang X, Zhou SF and Zhang Q: Self-microemulsifying drug delivery system improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice. European Journal of Pharmaceutics & Biopharmaceutics 2008; 69:899-907.
28. Patel AR and Vavia PR: Preparation and in vivo evaluation of self- microemulsifying drug delivery system containing fenofibrate. AAPS Journal 2007; 3:344-352.
29. Shen HR and Zhong MK: Preparation and evaluation of self- microemulsifying drug delivery systems containing atorvastatin. Journal of Pharmacy & Pharmacology 2006; 58:1183-1191.
30. Zhang P, Liu Y, Feng N and Xu J: Preparation and evaluation of self- microemulsifying drug delivery system of oridonin. International Journal of Pharmaceutics 2008; 355:269-276.
31. Patro MN and Yadav AV: Formulation design and evaluation of self- microemulsifying drug delivery system of valproic acid. Jordan Journal of Pharmaceutical Sciences 2010; 2:117-125.
32. Wu X, Xu J, Huang X and Wen C: Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability. Drug Development & Industrial Pharmacy 2010; 37:1-10.
33. Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, Lee HB and Cho SH: Development of self-microemulsifying drug delivery systems for oral bioavailability enhancement of simvastatin in beagle dogs. International Journal of Pharmaceutics 2004; 274:65-73.
34. Venkatesh G, Majid MIA, Mansor SM, Nair NK, Croft SL and Navaratnam V: In vitro and in vivo evaluation of self- microemulsifying drug delivery system of buparvaquone. Drug Development & Industrial Pharmacy 2010; 36:735-743.
35. Dixit AR, Rajput SJ and Patel SG: Preparation and bioavailability assessment of SMEDDS containing valsartan. AAPS Pharmaceutical Sciences & Technology 2010; 1:314-321.
36. Bachhav YG and Patravale VB: SMEDDS of glyburide: Formulation, in vitro evaluation and stability studies. AAPS Pharmaceutical Sciences & Technology 2009; 2:481-487.
37. Cui SX, Nie SF, Wang CG and Pan WS: Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine. Drug Development & Industrial Pharmacy 2009; 35:603-611.
38. Mullertz A, Ogbonna A, Ren S and Rades T: New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. Journal of Pharmacy & Pharmacology 2010; 62:1-15.
39. Patel MJ, Patel SS, Patel NM and Patel MM: A self-microemulsifying drug delivery system. International Journal of Pharmaceutical Sciences Review & Research 2010; 4:29-35.
40. Tolle S, Zuberi T and Lawrence MJ: Physiochemical and der- solubilisation properties of N, N-dimethyl-N-(3-dodecyloxy propyl) amine oxide: a biodegradable nonionic surfactant. Journal of Pharmaceutical Sciences 2000; 89:798-806.
41. Lawrencea MJ and Reesb GD: Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev 2000; 45:89-121.
42. Kimura M, Shizuki M, Miyoshi K, Sasai T, Hidaka H, Tatakamura H and Matoba T: Relationship between the molecular structures and emulsification properties of edible oils. Bioscience Biotechnology Biochemistry 1994; 58:1258-1261.
43. Kamble AV, Jagdale DM and Kadam VJ: Self-micro emulsifying drug delivery system. International Journal of Pharma & Bio Sciences 2010; 1:2-8.
44. Narang AS, Delmarre D and Gao D: Stable drug encapsulation in micelles and microemulsions. International Journal of Pharmaceutics 2007; 345:9-25.
45. Crison JR and Amidon GL, 1999. Methods and formulation for increasing the bioavailability of poorly water-soluble drugs. US Patent 5993858.
46. Hauss DJ, Fogal SE, Ficorilli JV, Price CA, Roy T, Jayaraj AA and Keirns JJ: Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. Journal of Pharmaceutical Sciences 1998; 87:164-169.
47. Yuasa H, Sekiya M, Ozeki S and Watanabe J: Evaluation of milk fat globule membrane (MFGM) emulsion for oral administration: absorption of α-linolenic acid in rats and the effect of emulsion droplet size. Biological & Pharmaceutical Bulletin 1994; 17:756-758.
48. Georgakopoulos E, Farah N and Vergnault G: Oral anhydrous nonionic microemulsions administrated in softgel capsules. Bulletin Technique Gattefosse 1992; 85:11-20.
49. Bose S and Kulkarni PK: Self emulsifying drug delivery systems: A review. Indian Journal of Pharmaceutical Education 2002; 36:184- 190.
50. Ganesh S, Shantanu K, Pravin K, Ashwin K, Rajesh K and Bhanudas K: Self-microemulsifying drug delivery system: A novel approach for hydrophobic drugs. International Journal of Pharmaceutical Sciences 2011; 3:988-1005.
51. Shaji J and Joshi V: Self-microemulsifying drug delivery system (SMEDDS) for improving bioavailability of hydrophobic drugs and its potential to give sustain release dosage form. Indian Journal of Pharmaceutical Education 2005; 39:130-135.
52. Patel M.V. and Chen F.J., 2002. Compositions and methods for improved delivery of hydrophobic agents. United States Patent 6451339.
53. Barthelemy P. and Benameur H., 2001. Composition with sustained release of active principle capable of forming microemulsion. United State Patent 6309665.
54. Zhang P, Liu Y, Feng N and Xu J: Preparation and evaluation of self- microemulsifying drug delivery system of oridonin. International Journal of Pharmaceutics 2008; 355:269-276.
55. Fregonezi-Nery MM: Determination of albendazole in oral suspension. Analytical Letters 2001; 34:1255-1263.
56. Borhade V, Nair H and Hegde D: Design and evaluation of self- microemulsifying drug delivery system (SMEDDS) of tacrolimus. AAPS Pharmaceutical Sciences & Technology 2008; 9:13-21.
57. Mukherjee T and Plakogiannis FM: Development and oral bioavailability assessment of a supersaturated self-microemulsifying drug delivery system of albendazole. Journal of Pharmacy & Pharmacology 2010; 62:1112-1120.
58. Patrick H, Nigel MD and Uwe V: Pseudo-ternary phase diagram of aqueous mixtures of Quil A cholesterol and phospholipids prepared the lipid film hydration method. International Journal of Pharmaceutical Sciences 2004; 270:229-39.
59. Martin A, "A book on physical pharmaceutical sciences", Lippincott Williams, UK, Fourth Edition., 1999, 156-71.
60. Pouton CW: Self-emulsifying drug delivery system: Assessment of the efficiency of emulsification. International Journal of Pharmaceutics 1985; 27:335.348.
61. Craig DQM, Barker SA, Banning D and Booth SW: An investigation into mechanism of size analysis and low frequency dielectric spectroscopy. International Journal of Pharmaceutics 1995; 114:103- 110.
62. Patil P, Joshi J and Paradkar P: Effect of formulation variables on preparation and evaluation of gelled self-emulsifying drug delivery system (SEDDS) of ketoprofen. AAPS Pharmaceutical Sciences & Technology 2004; 5:34-42.
63. Patil P, Vandana P and Paradkar P: Formulation of self-emulsifying drug delivery system for oral delivery of simvastatin: In vitro and in vivo evaluation. Acta Pharmaceutica 2007; 57:111-122.
64. Myers RA and Stella VJ: Factors affecting the lymphatic transport of penclomedine (NSC-338720), a lipophilic cytotoxic drug: Comparison to DDT and hexachlorobenzene. International Journal of Pharmaceutics 1992; 80:511-62.
65. Khoo SM, Porter CJ, Edwards GA and Charman WN: Intestinal lymphatic transport is the primary route for halofantrine after oral postprandial administration. Pharmaceutical Sciences 1999; 1:S- 624.
66. Gershanik T and Benita S: Positively-charged self-emulsifying oil formulation for improving oral bioavailability of progesterone. Pharmaceutical Development & Technology 1996; 1:147-157.
67. Khoo SM, Shackleford DM and Porter CJ: Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit dose lipid-based formulation to fasted dogs. Pharmaceutical Research 2003; 20:1460-65.
68. Patro MN, Bankar AS, Rakesh SU, Yadav AV: Oral lipid based formulation: A review. International Journal of Pharma & Bio Sciences 2010; 1:1-14.
69. Vergote GJ, Vervaet C, Van DI, Hoste S, De SS, Demeester J, Jain RA, Ruddy S and Remon J P: An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. International Journal of Pharmaceutics 2001; 219:81-87.
70. Yamada T, Onishi H and Machida Y: Sustained release ketoprofen microparticles with ethyl cellulose and carboxy methyl ethyl cellulose. Journal of Control Release 2001; 75:271-281.
71. Roda A, Sabatini L, Mirasoli M, Baraldini M and Roda E: Bioavailability of a new ketoprofen formulation for once-daily oral administration. International Journal of Pharmaceutics 2002; 241:165-172.
72. El-Kamel AH, Sokar MS, Al Gamal SS and Naggar VF: Preparation and evaluation of ketoprofen floating oral delivery system. International Journal of Pharmaceutics 2001; 220:13-21.
73. Gursoy N, Garrigue JS, Razafindratsita A, Lambert G and Benita S: Excipient effects on in vitro cytotoxicity of a novel paclitaxel selfemulsifying drug delivery system. Journal of Pharmaceutical Sciences 2003; 92:2420-2427.
74. Gershanik T, Benzeno S and Benita S: Interaction of the self- emulsifying lipid drug delivery system with mucosa of everted rat intestine as a function of surface charge and droplet size. Pharmaceutical Research 1998; 15:863-869.
75. Yi T, Wan J, Xu H and Yang X: A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. European Journal of Pharmaceutics &. Biopharmaceutics 2008; 70:439-44.
76. Sander C and Holm P: Porous magnesium aluminometasilicate tablets as carrier of a cyclosporine self-emulsifying formulation. AAPS Pharmaceutical Sciences & Technology 2009; 10:1388-1395
77. Dixit RP and Nagarsenker MS: Optimized microemulsion and solid microemulsion systems of simvastatin: Characterization and in vivo evaluation. Journal of Pharmaceutical Sciences 2010; 99:4892-4902.
78. Wei-san P, Lei T, Xin T, Ting-ting Y, Lan-lan W and Pei-nan S: Use of solid smedds in delivery of carvedilol. Journal of Chin Pharmaceutical Sciences 2006; 15:223-227.
79. Kumar P and Mital K L: Handbook of microemulsion: Science and Technology. Marcel Dekker, New York, Basel, First Edition 1999.
80. Farah N, Laforet JP and Denis J: Self-microemulsifying drug delivery systems for improving dissolution of drugs: in vitro evaluations presented by Gattefosse patented technology, AAPS annual meeting in San Diego, 1994, pp 41.
81. Charman WN, Porter CJ, Mithani S and Dressman JB: Physiochemical physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. Journal of Pharmaceutical Sciences 1997; 86:269-82.
82. Shukla JB, Koli AR,. Ranch KM and Parikh RK: Self-microemulsifying drug delivery. International Journal of Pharmacy & Pharmaceutical Sciences 2010; 1(2):15-33.
83. Legen I., Kerc J. and Jurkovic P., 2010. Self-microemulsifying drug delivery systems. US 2010/0331356.
84. Voorspoels J.F.M., 2007. Self-microemulsifying drug delivery systems of a HIV protease inhibitor. US 0104740 A1.
85. Crison J. R. and Amidon G. L., 2009. Method and formulation for increasing the bioavailability of poorly water-soluble drugs. US 1999/5,993,858.
86. Jing L., 2006. Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10. US 0275358.
87. Philippe B. and Hassan B., 2001. Composition with sustained release of active principle, capable of forming a microemulsion. US 6309665.
88. Lee B. J., Lee D. W. and Choi C. Y., 2004. Compositions containing itraconazole and their preparation methods. US 0248901.